Rho

A full-service CRO

Fully distributed

There is no central office. All members of the team work remotely.

👥201-500

📍Chapel Hill, NC

Rho

About Rho

Rho is a pharmaceuticals company that offers clinical drug development services.

What Rho is building

With a demonstrated track record of success, we guide our clients through the most appropriate program strategies, navigate the unique challenges of clinical trials, and drive development of the high-quality marketing applications demanded by regulatory authorities.

Technologies used at Rho

Front-end (2)

iOS (1)

Android (1)

HTML

jQuery

Company culture

Integrity

Strict adherence to a very high moral and ethical code is the keystone in Rho’s strong arch of core values. We demonstrate our integrity in relationships within Rho, beyond Rho, and in the manner in which we conduct scientific research and business. We behave honorably and honestly, take responsibility for our actions, forgive the honest mistakes of others, and treat others as we wish to be treated.

Quality

A high-quality customer experience matched with high-quality science has always been Rho’s passion. We satisfy internal and external customers time and again by listening carefully, thoroughly understanding, and then tailoring a solution to meet their needs. By caring, we create quality.

Funding rounds

Last funding round type

Seed

Company type

For Profit

Rho news and updates

Rho, Inc. hired J. Marc Pipas as Senior Medical Director on Oct 19th 22'.

Research Triangle Park, NC – October 19, 2022 – Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, today announced the appointment of J. Marc Pipas, MD, a leading oncologist, as Senior Medical Director.

Oct 18, 2022 | rhoworld.com

Rho, Inc. hired Gladwell as COO on May 1st 21'.

Ms. Gladwell was appointed as COO of Rho in May 2021.

Jan 1, 2022 | rhoworld.com

Rho, Inc. hired Peter Schmidt as SVP, Government Partnerships, Executive Committee Member Research on Apr 19th 22'.

Rho Appoints Peter Schmidt, Ph.D., as SVP, Government Partnerships, Executive Committee Member Research Triangle Park, NC – April 19, 2022 – Rho, a global full-service contract research organization (CRO) with a proven track record of drug development success, has appointed Peter Schmidt, Ph.D., as Senior Vice President, Government Partnerships of Rho’s Federal Systems Division.